Gemin X Biotechnologies was acquired by Cephalon on March 22, 2011

Life ScienceCompany

Out of 60 sectors in the Mergr database, life science ranked 11 in number of deals in 2011. The largest life science acquisition in 2011 was Genzyme - which was acquired by Sanofi SA for $20.1B.

Join Mergr to view all 169 acquisitions of life science companies in 2011, including 22 acquisitions by private equity firms, and 147 by strategics.

Gemin X Biotechnologies, Inc.

3576 Avenue du Parc, Suite 4310,
Montreal, Quebec H2X 2H7
Canada,
(514) 281-8989
www.geminx.com

Gemin X Biotechnologies Inc. is a biopharmaceutical company that engages in the discovery and development of small molecule cancer therapeutics based on the regulation of apoptosis. The company develops small molecules that target pathways for cancer, including regulators in the genesis and progression of cancer.


 Subscribe to unlock this and 178,413
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.3K Private Equity Firms
  • 168K M&A Transactions
  • 174K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.4K M&A Advisors
    (Investment Banks and Law Firms)
  • 63K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.